Helmerich & Payne heads into tonight's Q2 2026 earnings release having already delivered its sharpest rally in months — and with short sellers visibly retreating.
The stock closed Wednesday at $41.05, up nearly 13% on the week and over 13% in the past month alone. That move has pushed HP well above the mean analyst price target of $38.40, a mild but notable inversion: the stock is trading ahead of consensus Street estimates just as the company steps up to report. The RSI14 now reads 67.45 — elevated but not yet at overbought extremes — and the YTD gain is running at roughly 35%. The rally has come in a sector broadly moving higher, but HP's pace has been faster than most of its peer group.
Short sellers have not been adding to positions into strength. Short interest as a percentage of free float has eased from a mid-month peak of around 8.8% to 8.1%, with the bulk of that decline coming this week — a drop of roughly 5% in share terms over seven days. The official FINRA fortnightly count shows 8.0 million shares short, consistent with the ORTEX daily estimate. Borrowing costs remain modest at 0.42% APR, offering no sign of stress in the lending market. Borrow availability is generous: utilisation of lending supply has only reached 7.4% — far from the 52-week peak of 22.4% — meaning plenty of capacity for new short positions if sentiment were to shift post-earnings. The current setup looks comfortable rather than pressured.
Options positioning adds a mild bullish lean. The put/call ratio has eased to 0.51, fractionally below its 20-day mean of 0.52 and about 1.1 standard deviations below that average — a very slight tilt toward call activity rather than defensive hedging. Given the 52-week PCR range of 0.49 to 1.00, the current reading places options traders firmly at the bullish end of the historical spectrum. There is no sign of elevated downside protection going into the number.
The Street's view on HP is more nuanced than the rally might suggest. The consensus still leans to a hold, with Morgan Stanley maintaining an Underweight while lifting its target to $35 earlier this month — still well below the current price. Piper Sandler is the main constructive voice, nudging its target to $41 and maintaining an Overweight, effectively matching the current stock level. Susquehanna also held its Positive stance with a $42 target. Collectively, the mean target of $38.40 implies a haircut of roughly 6% from Wednesday's close — the stock has rallied into and arguably past what the Street collectively thinks it is worth. The EV/EBITDA multiple has expanded to 6.9x, up modestly over both the past week and month, while the price-to-book ratio has moved to 1.52x. Neither is extreme for the sector, but both have been drifting higher with the share price. EPS momentum is strong over 30 days, ranking in the 83rd percentile of the universe, though the 90-day reading is considerably more subdued at the 18th percentile — a reminder that the recent estimate trend has been better than the longer-run picture.
Institutional ownership is broad and the register is dominated by index and quasi-index holders. BlackRock has added around 253,000 shares to reach 14.7%, and Invesco has been the more active accumulator recently, adding roughly 460,000 shares to hold 3.1% of the company. Encompass Capital, an energy-focused hedge fund, holds 2.1% after what was a large build in a prior quarter. On the insider side, the most notable recent transaction was the Chief Legal Officer selling $2.15 million worth of shares in March at $36.62 — a price now comfortably in the money relative to that exit — though routine compensation-related awards and small sells in January round out the picture without offering a strong directional signal.
Post-earnings price reactions have been muted in recent history. The February 2026 print produced a 1-day move of negative 2.7%, with the stock then drifting a further 1% lower over five days. The prior event in early February showed a negative 1.2% day-one response and a sharper 9.7% pullback over the following week. Against that backdrop, the key question for the note today is whether a stock that has already re-rated 13% in a month can hold those gains once the catalyst lands — or whether the earnings result, whatever it says, simply invites profit-taking from those who bought into the move. Peers NBR and PTEN were also strong on the week, up 20% and 14% respectively, suggesting the sector tailwind is real; but SLB added only 2.5%, a reminder that the recovery has been uneven.
With the Q2 earnings call scheduled for tonight, the watch points are rig count trends, pricing power commentary, and any guidance revision — factors that will determine whether the premium the market has built in over the past month is justified or gets trimmed back.
See the live data behind this article on ORTEX.
Open HP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
